Drug-coated Balloons in the Femoropopliteal Region: Dream or Reality? | Zendy

Fabrizio Fanelli | Zendy; Alessandro Cannavale | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drug-coated Balloons in the Femoropopliteal Region: Dream or Reality?

Author(s) -

Fabrizio Fanelli,

Alessandro Cannavale

Publication year - 2018

Publication title -

vascular and endovascular review

Language(s) - English

Resource type - Journals

eISSN - 2516-3302

pISSN - 2516-3299

DOI - 10.15420/ver.2018.11.2

Subject(s) - medicine , atherectomy , lesion , superficial femoral artery , arterial disease , balloon , femoral artery , radiology , popliteal artery , artery , drug , angioplasty , surgery , vascular disease , restenosis , stent , pharmacology

Since their introduction in Europe in 2008, drug-coated balloons (DCBs) have increasingly been used for lower limb revascularisation. Following initial excellent results reported in the literature, many physicians started to use DCBs daily as a first-line therapy in the femoropopliteal region, supported by level 1 evidence. DCBs achieve high rates of primary patency (PP), compared with alternative therapies, with a limited use of provisional stents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research